Merck develops new technology to address solubility and speed to market challenges of ADCs
Merck has launched new technology and is set to expand manufacturing capacity to advance antibody-drug conjugates (ADC) therapies.
Archives for October 28, 2021
Biotecnica develops peptones ‘significantly less costly’ than ultrafiltered equivalents
Biotecnica has launched a new line of low endotoxin peptones that do not require ultrafiltration.
Rentschler tie-up with XL-protein expands CDMO’s growing biotechnological toolbox
Rentschler Biopharma and XL-protein have teamed up on the manufacture of what they say is a long-acting, hyperactive recombinant human deoxyribonuclease I (DNase I) that may open better treatment options for patients suffering from inflammation, chronic...